Activity of imipenem/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility

Activity of imipenem/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility

Show other versions (2)

Background and Objectives: Imipenem/relebactam (IMP/R) is a newly FDA approved β-lactam/β-lactamase inhibitor combination. Relebactam ability to restore IMP activity could differ according to the cause of imipenem non-susceptibility. Therefore, we investigated the in-vitro activity of IMP/R against...

Full description

Bibliographic Details
Main Authors: Mervat El-Sayed Mashaly, Ghada El-Saeed Mashaly
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2021-12-01
Series:Iranian Journal of Microbiology
Subjects:
Beta lactamases;
Klebsiella pneumoniae;
Polymerase chain reaction;
Imipenem;
Relebactam
Online Access:https://ijm.tums.ac.ir/index.php/ijm/article/view/3234

Internet

https://ijm.tums.ac.ir/index.php/ijm/article/view/3234

Similar Items